In contrast to drugs or biologics, medical devices accomplish their objectives through the physical, underlying, or mechanical activity as opposed to synthetic or metabolic activity inside or on the body. Straightforward, generally safe (Class-I) devices like tongue depressors, medical thermometers, dispensable gloves, and chamber pots are models, as are mind-boggling, high-risk (Class-II) devices that are embedded and drag out life.
The rising pervasiveness of persistent circumstances and the treatment of patients experiencing these sicknesses is applying tremendous strain on the medical care frameworks of numerous nations. The general expenses of treating a patient in a clinic ongoing setting are essentially higher, and longer emergency clinic stays are related to a higher monetary weight.
In this manner, with the endeavors taken by medical services organizations to move patients towards home consideration settings, additionally, market players are effectively putting resources into innovative work of cutting edge and simple to-utilize medical hardware, for example, particular beds, individual lifting, and moving gear, and toileting helps for the therapy of constant sicknesses.
North America accounted biggest market share in Medical Devices Market. This is credited to the rising predominance of ongoing sicknesses like a malignant growth, cardiovascular problems, diabetes, Persistent Obstructive Aspiratory Infection (COPD), Alzheimer’s, heftiness, and joint inflammation among others. Asia-Pacific is viewed as the quickest-developing medical devices market.
Medical Devices Market Forecast to 2030
Saudi Arabia medical devices market is entitled to exhibit rampant market growth during the forecast period of 2020 to 2027. Major factors facilitating the market growth are the flourishing medical device industry, the rising burden of chronic diseases, growing medical tourism, and the expansion of the private healthcare system. In contrast, the shortage of healthcare professionals (HCP) in the region is anticipated to restrain the market growth during the forecast period. The other growth factors include the rising prevalence of non-communicable diseases and the increasing population in the region.
Saudi Arabia Medical Device Market Research Report Forecast to 2027
Top 10 Medical Device Technologies in 2023 and Future
U.S. Orthopedic Imaging Modalities and Orthopedic Surgical Navigation Systems Market Prospect
The U.S. orthopedic imaging modalities market is estimated to reach $3,989.9 million in 2031, reveals the premium market intelligence study by CRI Report. The study also highlights that the market is set to witness a CAGR of 4.44% during the forecast period 2022-2031.
- In Vitro Diagnostic (IVD) Devices
- Immunoassays
- Clinical Chemistry
- Microbiology
- Molecular Diagnostics
- Hematology
- Coagulation & Hemostasis
- Others
In-vitro diagnostics (IVD) are medical devices, reagents, and accessories used to perform tests on samples, (e.g., blood, urine, and tissue) taken from the human body to help detect infection, diagnose a medical condition, and prevent disease. IVD plays a major role in the early diagnosis and management of diseases.Â
Microbiology
The global industrial microbiology market has witnessed high growth in the last decade. The increase in demand for industrial microbiology products can largely be attributed to factors such as increase in the significance of industrial food and safety, growing awareness among researchers about new strains of microorganisms, increasing demand for pathogen testing in food products, growing research initiatives in different fields of industrial microbiology, increasing automation in products, and rising number of collaborations among companies.
The global industrial microbiology market was valued to be $5,604.2 million in 2019 and is expected to reach $13,181.2 million by 2030, witnessing a CAGR of 8.36% during the forecast period 2020-2030.
Global Industrial Microbiology Market: Focus on Products, Applications, End Users, Country Data (13 Countries), and Competitive Landscape – Analysis and Forecast, 2020-2030
The market growth can mainly be attributed to the growing research in the field of industrial microbiology, increasing awareness among researchers about new strains of microorganisms, rise in preference toward consumer products, increase in research and development as well as collaborations in pharmaceutical and biotechnology industries, and use of rapid sterility testing methods for pathogen detection.
Molecular Diagnostics
Diagnostic tests provide critical insights at every stage of medical care – right from the genetic tests providing information about personalized cancer treatment to the microbial culture identifying accurate antibiotics against an infection.
The molecular diagnostics market to be one of the stable markets, and the global market is predicted to grow from $10,914.6 million in 2020 to $24,228.0 million in 2031 and is expected to grow with a CAGR of 7.38% during the forecast period 2021-2031.
Molecular Diagnostics Market-Analysis and Forecast,2021-2031
Factors fueling the growth of the market include a highly increasing prevalence of infectious diseases and various types of cancer, an increase in awareness and acceptance of personalized medicines on a global level, and significant external funding for executing research and development exercises. Despite rapid advanced industry growth, several key issues need to be addressed to facilitate future growth.
Coagulation
Coagulation can happen because of a lot of reasons. The blood coagulation testing market has higher reception because of an ascent in speculation. Reception of these testing innovations prompts successful and effective treatment for blood issues.
Global blood coagulation testing market is anticipated to register a significant CAGR during the review period. It is an interactive examination of the time term of blood coagulating. This interaction is vital during the time spent in unreasonable draining conditions.
Blood Coagulation Testing Market Forecast till 2027
The extension of medical services offices is acquiring good changes in the blood coagulation testing market. With countless centers and clinics, the treatment for these issues is speedy. Likewise, with more clinics, the reception of blood coagulation testing rises.
The commonness of cardiovascular and blood issues is a pivotal driver for the blood coagulation testing market. Lately, the pace of blood issues is flooding. Cardiovascular sicknesses and their manifestations require blood coagulation testing.
Additionally, blood problems require this testing system for additional treatment. Moreover, the requirement for powerful treatment for hemophilia, liver infection, and thrombophilia is enormous. These conditions can prompt inordinate dying.
This large number of conditions require blood coagulation testing to make the blood plasma into strong gels. The demand for blood coagulation for these medicines will prompt striking demand in the blood coagulation testing market.
Further, government speculations to improve well-being foundation is a critical driver. The administrative drive is an excellent help to the well-being of the business. Through these ventures establishment of new clinical gadgets is conceivable.
- Cardiology Devices
- Cardiovascular Monitoring Diagnostics Devices
- Cardiac Rhythm Management Devices
- Interventional Cardiology Devices
- Peripheral Vascular Devices
- Prosthetic Devices
- Cardiac Surgery Devices
- Electrophysiology Devices
- Diagnostic Imaging Devices
- Ultrasound
- X-ray
- Nuclear Imaging
- MRI
- Computed Tomography
- Orthopedic Devices
- Orthobiologics
- Joint Reconstruction
- Spinal Surgery Devices
- Trauma Fixation Products
- Arthroscopic Devices
- Orthopedic Accessories
- Orthopedic Braces & Supports
- Ophthalmology Devices
- Diagnostic & Monitoring Devices
- Refractive Surgery Devices
- Glaucoma Surgery Devices
- Cataract Surgery Devices
- Vitreoretinal Surgery Devices
- Vision Care
- Endoscopy Devices
- Endoscopes
- Visualization Equipment
- Other Instruments
- Endoscopy Accessories
- Diabetes Care Devices
- Diabetes Monitoring Devices
- Insulin Delivery Devices
- Wound Management Devices
- Traditional Wound Care
- Basic Wound Care
- Advanced Wound Care
- Bioactive Wound Care
- Therapy Devices
- Kidney/Dialysis Devices
- Hemodialysis Products
- Peritoneal Dialysis Products
- Anesthesia and Respiratory Care Devices
- Anesthesia Devices
- Respiratory Devices
Drug Delivery System
Ophthalmic Drug Delivery Devices Market Overview
Global ophthalmic drug delivery devices market involves various drug delivery devices used in ophthalmic drug delivery. The considered devices include pre-filled syringes, multidose eyedroppers, drug-eluting contact lenses, technology-enabled add-on devices, mist sprayers, squeeze dispensers, and other devices such as tubes and ocular inserts.
The factors driving growth include increasing prevalence of ocular disorders, development of novel drug dispensers, integration of digital solutions in ophthalmic drug delivery devices, and regular funding cycles for emerging companies. The restraints for the global ophthalmic drug delivery devices market include high upfront cost of the advanced ophthalmic drug delivery devices and prolonged regulatory approval process. Furthermore, there are various opportunities in the market that hold considerable growth potential. Entry of regional companies in the global ophthalmic drug delivery devices market, partnerships between companies and ophthalmic clinics, and inclusion of nanotechnology in ophthalmic drugs formulation are the key opportunity areas in the global ophthalmic drug delivery devices market.
the market was valued at $295.4 million in 2020 and is expected to reach $537.8 million by the end of 2030. The market is expected to grow at a CAGR of 6.17% during the forecast period from 2021 to 2030.
Global Ophthalmic Drug Delivery Devices Market: Focus on Product, Formulation, Sales Channel, End User, and 21 Countries – Analysis and Forecast, 2021-2030
The factors driving growth include increasing prevalence of ocular disorders, development of novel drug dispensers, integration of digital solutions in ophthalmic drug delivery devices, and regular funding cycles for emerging companies. The rising prevalence of ocular disorders has also increased the global prevalence of blindness. For instance, according to a study published in Lancet, in December 2020, titled ‘Causes of Blindness and Vision Impairment In 2020 and Trends Over 30 Years, and Prevalence of Avoidable Blindness in Relation to VISION 2020: The Right to Sight: An Analysis for the Global Burden of Disease Study,’ cataract was the major cause of blindness. Furthermore, other ocular disorders such as glaucoma, uncorrected refractive error, age-related macular degeneration, and diabetic retinopathy are also the causes of blindness.
To overcome the shortcomings of conventional eye droppers, various companies operating in the market have developed either novel dispensing systems or advanced eyedroppers. For instance, companies such as AptarGroup, Inc. and Owen Mumford have developed squeeze dispensers for ophthalmic drug delivery. Furthermore, companies such as Nemera, Aero Pump GmbH, and Berry Healthcare have developed advanced eye droppers with a focus on preservative-free formulation and ease of usage.
Furthermore, owing to the rising digitization in the global healthcare system, advancements in drug delivery systems, rising focus on medication adherence, and high cost of drug non-adherence, the ophthalmic drug delivery devices have witnessed digital solutions integration. Companies such as Nemera have developed digital devices for ensuring medication adherence and compliance with the prescribed therapy by the patient. Furthermore, Aptar Group, Inc., in association with Kali Care, has developed connected solutions for ensuring optimum eye care.
Furthermore, emerging companies such as Kedalion Therapeutics, Inc., Re-Vana Therapeutics, and Ocumedic, Inc also operate in the global ophthalmic drug delivery devices market. These companies have a strong product pipeline of advanced drug delivery devices with a focus on minimal drug wastage. Moreover, the companies receive regular fundings that ensure constant product development and research and development (R&D) activities.
New product launches are one of the primary strategies adopted by new companies to enter the global ophthalmic drug delivery devices market. Companies have also been working on upgrades for their existing products. Between January 2018-June 2021, several new products were launched in the global ophthalmic drug delivery devices market. Companies such as Gerresheimer AG, Hoffman Neopac AG, Ocular Therapeutix, Inc., and Silgna Holdings, Inc. launched their products in the mentioned period. Furthermore, funding activities are critical for the entry and operation of start-ups in the global ophthalmic drug delivery devices market. Re-Vana Therapeutics, Credence MedSystems, Inc., and Kedalion Therapeutics, Inc. are the prominent companies in the global ophthalmic drug delivery devices market that have received funding for their product development and R&D efforts.
Connected Drug Delivery Devices Market
Connected drug delivery devices are the kind of machines which are used to provide various medicinal agents in a patient’s body to offer medical treatment and monitor a patient’s behavior. These machines are used to decrease patients’ non-adherence regarding medicinal prescriptions and to proffer improved health solutions.
Connected Drug Delivery Devices Market to surpass USD 1.03 billion by 2031 from USD 0.24 billion in 2021 at a CAGR of 15.4% within the coming years, i.e., 2021-31.
Connected Drug Delivery Devices Market : Segmented By Technology (Bluetooth, NFC and Others): By End-User Product (Connected Sensors, Integrated Connected Devices and Others) Global Analysis By Market Size, Share & Trends For 2020-2021 And Forecasts To 2031
Amplified patient engagement and connectivity due to the rising penetration of the Internet of Things (IoT) in the medical devices segment is projected to drive the market. The product is anticipated to continue to witness growth in the future as well due to the increasing emphasis on the current demand of improved patient compliance and quality of care, increasing awareness regarding production footprint and associated costs, and rising use of self-administered and connected drug therapy.
Invasive Devices
Active Implantable Medical Devices Market
Active implantable medical device refers to any active medical device that is intended to be inserted in a natural orifice, completely or partially, surgically or medically, into the human body or by medical intervention, and which is intended to stay in place after the operation. AIMDs are subject to both pre-and post-market strict regulatory controls.
Active implantable medical devices are operated devices that are implanted, either through a natural orifice or through surgical means, into the body of a patient and are intended to stay after the operation in the patient’s body. Usually, such instruments are battery-powered, and the power supply may be either contained in the instrument or attached to wires protruding from the body of the patient.
Implementations in this group range from blood oxygen level monitor to sophisticated heart-lung devices that can take over the cardiopulmonary functions of a patient during surgery.
The key growth drivers for the implantable and life-sustaining devices market are factors such as aging population growth, increasing prevalence of cardiovascular and neurological disorders, investments and funds for the production of technologically advanced goods, expanded applications of neurostimulators, and favorable reimbursement scenarios for ENT procedures in developed countries. In addition, rising chronic diseases and developments in successful implantable medical devices are expected to fuel the growth of the market over the forecast period.
Respiratory Therapeutic Devices
Respiratory Care Device Market
Medical equipment used for the diagnosis, management, care, control, treatment, and assessment of patients with cardiopulmonary disorders is referred to as a respiratory care device. These are used to treat degenerative lung disorders such as asthma, emphysema, chronic bronchitis, and other chronic and acute respiratory illnesses. Furthermore, monitoring equipment are critical for keeping track on the health of individuals with respiratory diseases. The World Health Organization (WHO) estimates that 235 million people will suffer from asthma by 2020. This denotes the necessity for asthmatic patients to get respiratory treatment.
Global Respiratory Care Device Market to surpass USD 60.29 billion by 2030 from USD 22.34 billion in 2020 at a CAGR of 10.44% in the coming years, i.e., 2021-30.
Global Respiratory Care Device Market Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030
The global pandemic of coronavirus has resulted in an unexpected increase in demand for respiratory care devices. Apart from that the high prevalence of respiratory illnesses, the global aging population, the high prevalence of smoking, rising urbanization and pollution levels, the rising incidence of preterm births, and lifestyle changes are all contributing to the market’s rise.
Electronic Medical Device
Non-Destructive Medical Device Market Analysis
The market is estimated at USD 13.9 Billion in the year 2020, is projected to reach a revised size of xx Billion by 2031, growing at a CAGR of 6.7% from 2021 to 2031.
Global Non-Destructive Medical Device Market Analysis and Forecast 2030
Leave a Reply